PCALCL: other treatments
| Therapy . | References . |
|---|---|
| Isotretinoin (syn-onym: 13-cis-retinoic acid) | 31,55 |
| Bexarotene, alone or in combination with IFN-α | 39,50,52 |
| IFN-α, IFN-γ | 39,50,51,93 |
| Topical imiquimod 5% | 53,54 |
| Thalidomide | 55 |
| Single-agent chemotherapy: gemcitabine, etoposide, intralesional and systemic MTX | 38,40,44,46,104,105 |
| Bone marrow or stem cell transplantation | 4,6,8,40,41 |
| Anti-CD30 antibody (SGN30) | 40,47,48 |
| Oral steroids | 52 |
| Excimer laser (308 nm) | 106 |
| Local thermotherapy | 107 |
| Therapy . | References . |
|---|---|
| Isotretinoin (syn-onym: 13-cis-retinoic acid) | 31,55 |
| Bexarotene, alone or in combination with IFN-α | 39,50,52 |
| IFN-α, IFN-γ | 39,50,51,93 |
| Topical imiquimod 5% | 53,54 |
| Thalidomide | 55 |
| Single-agent chemotherapy: gemcitabine, etoposide, intralesional and systemic MTX | 38,40,44,46,104,105 |
| Bone marrow or stem cell transplantation | 4,6,8,40,41 |
| Anti-CD30 antibody (SGN30) | 40,47,48 |
| Oral steroids | 52 |
| Excimer laser (308 nm) | 106 |
| Local thermotherapy | 107 |